ETF comparison

FHLCvsXBI

Both Healthcare.

Fidelity MSCI Health Care Index ETF · State Street SPDR S&P Biotech ETF

Holdings overlap

Weighted by ISIN/CUSIP
12.9%

117 positions appear in both funds. Buying equal dollars of FHLC and XBI would leave roughly12.9%of each dollar exposed to the same underlying securities.

FHLC only 87.0%Shared 12.9%XBI only 87.1%
In FHLC only
221 positions
Shared
117 positions
In XBI only
40 positions

Side by side

FHLC

Fidelity MSCI Health Care Index ETF

Fidelity · Healthcare

80composite / 100
Expense ratio
0.084%
Net assets
$3.48B
TTM yield
1.27%
Top-10 conc.
50.6%
XBI

State Street SPDR S&P Biotech ETF

State Street · Healthcare

81composite / 100
Expense ratio
0.35%
Net assets
$11.40B
TTM yield
0.36%
Top-10 conc.
18.0%

Sub-score comparison

92
Cost
65
83
Tax efficiency
85
80
Liquidity
100
42
Concentration
89
Tracking quality
FHLCsub-scoreXBI

Tracking quality isn't part of the composite — seewhat we don't scorefor why.

Cost difference

FHLC is 27 bps cheaper than XBI. On a $100,000 position that's about $266/yr more in fees for XBI.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open thecost calculator pre-filled with FHLC vs XBI.

Top shared holdings

117 shared in total
#HoldingIn FHLCIn XBIOverlap
1Vertex Pharmaceuticals Inc1.75%1.06%1.06%
2AbbVie Inc6.03%1.04%1.04%
3Amgen Inc3.01%0.99%0.99%
4Gilead Sciences Inc2.62%0.96%0.96%
5Regeneron Pharmaceuticals Inc1.18%0.96%0.96%
6Alnylam Pharmaceuticals Inc0.66%0.96%0.66%
7Insmed Inc0.47%1.08%0.47%
8Biogen Inc0.45%1.03%0.45%
9Natera Inc0.44%1.16%0.44%
10United Therapeutics Corp0.38%0.92%0.38%
11Revolution Medicines Inc0.38%1.20%0.38%
12Moderna Inc0.26%1.41%0.26%

Only in FHLC

221 total
  • Eli Lilly & Co12.13%
  • Johnson & Johnson8.94%
  • UnitedHealth Group Inc5.42%
  • Merck & Co Inc4.38%
  • Thermo Fisher Scientific Inc2.91%
  • Intuitive Surgical Inc2.62%
  • Abbott Laboratories2.55%
  • Pfizer Inc2.45%
  • Bristol-Myers Squibb Co1.99%
  • Danaher Corp1.84%

Only in XBI

40 total
  • SELLAS Life Sciences Group Inc1.19%
  • Summit Therapeutics Inc1.01%
  • Absci Corp0.56%
  • Hyperliquid Strategies Inc0.46%
  • Corvus Pharmaceuticals Inc0.41%
  • Avalo Therapeutics Inc0.35%
  • Jade Biosciences Inc0.32%
  • Vor BioPharma Inc0.30%
  • Replimune Group Inc0.28%
  • Sionna Therapeutics Inc0.27%

Open FHLC or XBI at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodologyand funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see/methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.